Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants

被引:169
作者
Spiecker, M
Darius, H
Kaboth, K
Hübner, F
Liao, JK
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, Vasc Med & Atherosclerosis Unit, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Mainz, Med Clin 2, D-6500 Mainz, Germany
关键词
atherosclerosis; inflammation; nuclear transcription factor;
D O I
10.1002/jlb.63.6.732
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although nitric oxide (NO) and antioxidants inhibit adhesion molecule expression, their inhibitory effects on nuclear factor kappa B (NF-kappa B) activation may differ. The NO donors, but not 8-bromo-cGMP, decreased tumor necrosis factor alpha (TNF-alpha)-induced VCAM-1, ICAM-1, and E-selectin expression by 11-70%. In contrast, NAC completely abolished VCAM-1 and E-selectin expression and decreased ICAM-1 expression by 56%. Gel shift assays demonstrate that NF-kappa B activation was inhibited by both NO and antioxidants. The activation of NF-kappa B involves the phosphorylation and degradation of its cytoplasmic inhibitor I kappa B-alpha by 26S proteasomes. The 26S proteasome inhibitor MG132 prevented the degradation of phosphorylated I kappa B-alpha. NAC inhibited I kappa B kinase (IKK) activity and prevented I kappa B-alpha phosphorylation and degradation. In contrast, NO did not inhibit IKK activity, I kappa B-alpha phosphorylation, or I kappa B-alpha degradation. However, NO, but not antioxidants, induced I kappa B-alpha promoter activity. Tbe inhibitory effects of NO on adhesion molecule expression, therefore, differs from that of antioxidants in terms of the mechanism by which NF-kappa B is inactivated.
引用
收藏
页码:732 / 739
页数:8
相关论文
共 44 条
[1]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[2]   APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].
BECKMAN, JS ;
BECKMAN, TW ;
CHEN, J ;
MARSHALL, PA ;
FREEMAN, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624
[3]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[4]   CARDIOVASCULAR ACTIONS OF THE FUROXAN CAS-1609, A NOVEL NITRIC-OXIDE DONOR [J].
BOHN, H ;
BRENDEL, J ;
MARTORANA, PA ;
SCHONAFINGER, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (08) :1605-1612
[5]   CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION [J].
BROWN, K ;
GERSTBERGER, S ;
CARLSON, L ;
FRANZOSO, G ;
SIEBENLIST, U .
SCIENCE, 1995, 267 (5203) :1485-1488
[6]   Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity [J].
Chen, ZJ ;
Parent, L ;
Maniatis, T .
CELL, 1996, 84 (06) :853-862
[7]   AUTOREGULATION OF I-KAPPA-B-ALPHA ACTIVITY [J].
CHIAO, PJ ;
MIYAMOTO, S ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :28-32
[8]  
COLLINS T, 1993, LAB INVEST, V68, P499
[9]  
COLLINS T, 1995, FASEB J, V9, P1
[10]   ENDOTHELIAL EXPRESSION OF A MONONUCLEAR LEUKOCYTE ADHESION MOLECULE DURING ATHEROGENESIS [J].
CYBULSKY, MI ;
GIMBRONE, MA .
SCIENCE, 1991, 251 (4995) :788-791